Targeted Treatments for Haematological Cancers
This course is ideal for doctors, senior research nurses, pharmaceutical employees, and trials staff with a science background.
This course describes the unique cellular and genetic features of haematological cancers and covers a diverse range of targeted treatments in development for leukaemia, lymphoma and multiple myeloma. New approaches such as epigenetic modifiers and inhibitors of Bcl-2 and B cell receptor signalling are introduced and the possibility of personalised treatment is discussed.
www.sciencecommunicated.co.uk